Print

Progenics Pharmaceuticals, Inc. (PGNX) to Webcast Investor and Analyst Day July 18, 2013  
7/17/2013 9:40:06 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., July 16, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) will webcast its upcoming investor and analyst day, taking place July 18, 2013 from 2:30pm – 5:30pm ET. Guest speakers Jonathan Simons, M.D., president & chief executive officer of the Prostate Cancer Foundation, and John Babich, Ph.D., co-founder and former CEO of Progenics' Molecular Insight subsidiary, will join Progenics executives in providing an update on commercial and pipeline products and candidates, business development and corporate outlook.

Help employers find you! Check out all the jobs and post your resume.

//-->